<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01802151</url>
  </required_header>
  <id_info>
    <org_study_id>177-2012</org_study_id>
    <nct_id>NCT01802151</nct_id>
  </id_info>
  <brief_title>Evaluation of Bacillus Subtilis R0179 in Healthy Young Adults</brief_title>
  <official_title>Evaluation of Bacillus Subtilis R0179 in Capsules on Gastrointestinal Survival, Transit Time, Gastrointestinal Symptoms, and General Wellness in Healthy Young Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lallemand Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of three doses of the probiotic B.
      subtilis (Bacillus subtilis R0179) delivered in capsules on gastrointestinal and general
      wellness in healthy young adults, survival through the gastrointestinal tract and impact on
      intestinal microbes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A 6 week randomized, double blind placebo controlled trial in healthy young adults aged 18 to
      50. Participants will be administered an oral dose of B. subtilis or placebo (1 capsule/day)
      for a period of 4 weeks. Viable counts will be measured from stool samples to assess transit
      survival, daily questionnaires (DQ) will be administered to assess general wellness, and
      gastrointestinal (GI) symptoms will be evaluated three times with the Gastrointestinal
      Symptom Response Scale (GSRS) questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for GI Distress</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Cephalic</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Epidermal</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Ear, Nose, and Throat (ENT)</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Behavioral</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Emetic</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Constipation</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Diarrhea</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Fatigue</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Satiety</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Bowel Movement</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Daily scores from weeks 2 - 5 were then averaged to arrive at a single value. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Hours of Sleep</measure>
    <time_frame>Weekly for 6 weeks</time_frame>
    <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Participants recorded the number of hours they slept on the daily questionnaire.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the Effect of B. Subtilis R0179 on Gastrointestinal Symptoms Using Questionnaires</measure>
    <time_frame>Weeks 1, 5, and 6</time_frame>
    <description>Gastrointestinal Symptom Questionaires (GSRS) was administered during weeks 1, 5, and 6 of the study to evaluate gastrointestinal symptoms. The scale ranges from 1 (no discomfort at all) to 7 (very severe discomfort).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the Survival of B. Subtilis R0179 and Analyzing the Microbial Diversity in Stool Samples by Participants (Microbiota Study)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Viability of B. subtilis R0179, recovered from stool samples, was assessed using one way ANOVA followed subsequently by Tukey-Kramer HSD when significance was reached (p&lt;0.05). Data was normalized when appropriate. Data analyzed was log (CFU/g).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B. subtilis R0179 (10 billion CFU)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
* CFU (Colony Forming Unit)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B. subtilis R0179 (1 billion CFU)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B. subtilis R0179 (0.1 billion CFU)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>B. subtilis R0179</intervention_name>
    <description>B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
    <arm_group_label>B. subtilis R0179 (10 billion CFU)</arm_group_label>
    <arm_group_label>B. subtilis R0179 (1 billion CFU)</arm_group_label>
    <arm_group_label>B. subtilis R0179 (0.1 billion CFU)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Participants

          -  Are 18-50 years of age

          -  Are willing and able to complete the Informed Consent Form in English

          -  Are willing to complete the GPAQ (Global Physical Activity Questionnaire) at baseline
             and during the last week of the study as well as completing the GSRS (Gastrointestinal
             Symptom Response Survey) questionnaire at baseline, during treatment and post
             treatment

          -  Are currently &quot;moderately active&quot; as determined by the GPAQ (Global Physical Activity
             Questionnaire)

          -  Are willing to have height and weight measured and to provide demographic information
             (age, race, sex)

          -  Are willing to consume B. subtilis R0179 (approximate doses of 1, 10, or 0.1 billion
             CFU per day) or placebo for a 28 day period by capsule (1 per day)

          -  Are willing to complete daily questionnaires regarding general and gastrointestinal
             wellness for the duration of the study

          -  Are willing to provide 1 stool at baseline, 1 stool during week 4 of the treatment and
             1 stool after 7 days of washout

          -  Are willing to provide a social security number to receive study payment. Note: the
             subject can still participate if unwilling to provide social security number, but no
             financial reimbursement can be provided

          -  Are willing to have internet access for the duration of the study

        Exclusion Criteria: Potential Participants will be excluded if they

          -  Do not meet the inclusion criteria

          -  Are currently taking medications for constipation or diarrhea

          -  Have taken antibiotics within the past four weeks prior to randomization

          -  Are currently taking probiotics supplements and do not want to discontinue a minimum
             of two weeks prior to the study

          -  Known to have or are currently being treated for any diseases or illnesses such as
             gastrointestinal disease (gastric ulcers, Crohn's, ulcerative colitis, etc.), other
             chronic diseases (diabetes, kidney disease, etc.) or immune-compromising diseases or
             conditions (HIV, AIDS, autoimmune, hepatitis, cancer, transplant patient etc.)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wendy J Dahl, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bobbi Henken-Langkamp, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Volker Mai, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/25062611</url>
    <description>Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults.</description>
  </link>
  <reference>
    <citation>Hong HA, Duc le H, Cutting SM. The use of bacterial spore formers as probiotics. FEMS Microbiol Rev. 2005 Sep;29(4):813-35. Epub 2004 Dec 16. Review.</citation>
    <PMID>16102604</PMID>
  </reference>
  <reference>
    <citation>Oelschlaeger TA. Mechanisms of probiotic actions - A review. Int J Med Microbiol. 2010 Jan;300(1):57-62. doi: 10.1016/j.ijmm.2009.08.005. Epub 2009 Sep 23. Review.</citation>
    <PMID>19783474</PMID>
  </reference>
  <reference>
    <citation>Sanders ME, Morelli L, Tompkins TA. 2003. Sporeformers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Comprehensive Reviews in Food Science and Food Safety; 2: 101-103.</citation>
  </reference>
  <reference>
    <citation>Tompkins TA, Hagen KE, Wallace TD, Fillion-Forté V. Safety evaluation of two bacterial strains used in Asian probiotic products. Can J Microbiol. 2008 May;54(5):391-400. doi: 10.1139/w08-022.</citation>
    <PMID>18449224</PMID>
  </reference>
  <reference>
    <citation>Tompkins TA, Xu X, Ahmarani J. A comprehensive review of post-market clinical studies performed in adults with an Asian probiotic formulation. Benef Microbes. 2010 Mar;1(1):93-106. doi: 10.3920/BM2008.1005. Review.</citation>
    <PMID>21840798</PMID>
  </reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2013</study_first_submitted>
  <study_first_submitted_qc>February 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2013</study_first_posted>
  <results_first_submitted>March 30, 2015</results_first_submitted>
  <results_first_submitted_qc>November 13, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 17, 2015</results_first_posted>
  <last_update_submitted>November 13, 2015</last_update_submitted>
  <last_update_submitted_qc>November 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>probiotics</keyword>
  <keyword>microbiota</keyword>
  <keyword>survival</keyword>
  <keyword>gastrointestinal</keyword>
  <keyword>wellness</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Healthy adults were recruited by flyers and word of mouth on the University of Florida campus. Rolling recruitment (7/02/2012–08/23/2012) occurred until the minimum number of participants (n=80) had been enrolled.</recruitment_details>
      <pre_assignment_details>A one week baseline period was to be completed before participants were randomized to intervention arms. Participants that failed to complete study requirements during this period were withdrawn due to noncompliance.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="P2">
          <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="P3">
          <title>B. Subtilis R0179 (1 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="P4">
          <title>B. Subtilis R0179 (10 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="22"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20">Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20</participants>
                <participants group_id="P2" count="21">Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20</participants>
                <participants group_id="P3" count="20">Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20</participants>
                <participants group_id="P4" count="20">Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants who completed all study requirements were included in the baseline analysis population. 2 participants in the 1 Billion CFU group were excluded from the baseline analysis because they did not complete all study requirements.</population>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="B2">
          <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="B3">
          <title>B. Subtilis R0179 (1 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="B4">
          <title>B. Subtilis R0179 (10 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="21"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="20"/>
            <count group_id="B5" value="81"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23" lower_limit="20" upper_limit="46"/>
                    <measurement group_id="B2" value="23" lower_limit="20" upper_limit="49"/>
                    <measurement group_id="B3" value="22" lower_limit="20" upper_limit="31"/>
                    <measurement group_id="B4" value="23" lower_limit="19" upper_limit="46"/>
                    <measurement group_id="B5" value="23" lower_limit="19" upper_limit="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI Percentiles</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;85th % (Healthy Weight)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>85th-94th % (Overweight)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;= 95th % (Obese)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Activity Level</title>
          <description>Minutes of physical activity were assessed according the Global Physical Activity Questionnaire</description>
          <units>mins of moderate and intense activity</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="185.5" spread="70.9"/>
                    <measurement group_id="B2" value="197.3" spread="84.5"/>
                    <measurement group_id="B3" value="168.3" spread="74.9"/>
                    <measurement group_id="B4" value="199.0" spread="57.9"/>
                    <measurement group_id="B5" value="185.9" spread="72.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for GI Distress</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for GI Distress</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (GI Distress) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.8"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.6" spread="0.1"/>
                    <measurement group_id="O4" value="0.7" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (GI Distress) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.1"/>
                    <measurement group_id="O2" value="0.4" spread="0.1"/>
                    <measurement group_id="O3" value="0.6" spread="0.1"/>
                    <measurement group_id="O4" value="0.5" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (GI Distress) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.1"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.6" spread="0.1"/>
                    <measurement group_id="O4" value="0.6" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (GI Distress) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.1"/>
                    <measurement group_id="O2" value="0.3" spread="0.01"/>
                    <measurement group_id="O3" value="0.7" spread="0.1"/>
                    <measurement group_id="O4" value="0.7" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (GI Distress) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.1"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.7" spread="0.1"/>
                    <measurement group_id="O4" value="0.5" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (GI Distress) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.1"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.6" spread="0.1"/>
                    <measurement group_id="O4" value="0.4" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Evaluation of the Survival of B. Subtilis R0179 and Analyzing the Microbial Diversity in Stool Samples by Participants (Microbiota Study)</title>
        <description>Viability of B. subtilis R0179, recovered from stool samples, was assessed using one way ANOVA followed subsequently by Tukey-Kramer HSD when significance was reached (p&lt;0.05). Data was normalized when appropriate. Data analyzed was log (CFU/g).</description>
        <time_frame>6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Survival of B. Subtilis R0179 and Analyzing the Microbial Diversity in Stool Samples by Participants (Microbiota Study)</title>
          <description>Viability of B. subtilis R0179, recovered from stool samples, was assessed using one way ANOVA followed subsequently by Tukey-Kramer HSD when significance was reached (p&lt;0.05). Data was normalized when appropriate. Data analyzed was log (CFU/g).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>log CFU/g</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GI Viability of Bacillus Spores Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.1"/>
                    <measurement group_id="O2" value="0.9" spread="0.1"/>
                    <measurement group_id="O3" value="0.9" spread="0.1"/>
                    <measurement group_id="O4" value="1.2" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI Viability of Bacillus Spores Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="0.1"/>
                    <measurement group_id="O2" value="4.6" spread="0.1"/>
                    <measurement group_id="O3" value="5.6" spread="0.1"/>
                    <measurement group_id="O4" value="6.4" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GI Viability of Bacillus Spores Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.1"/>
                    <measurement group_id="O2" value="1.3" spread="0.2"/>
                    <measurement group_id="O3" value="0.8" spread="0.1"/>
                    <measurement group_id="O4" value="2.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Cephalic</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Cephalic</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Cephalic) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.04"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Cephalic) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.04"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Cephalic) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.04"/>
                    <measurement group_id="O4" value="0.3" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Cephalic) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.03"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.3" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Cephalic) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Cephalic) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Epidermal</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Epidermal</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Epidermal) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.02"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.01" spread="0.01"/>
                    <measurement group_id="O4" value="0.03" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Epidermal) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.04"/>
                    <measurement group_id="O2" value="0.02" spread="0.01"/>
                    <measurement group_id="O3" value="0.04" spread="0.02"/>
                    <measurement group_id="O4" value="0.04" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Epidermal) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.03"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.04"/>
                    <measurement group_id="O4" value="0.05" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Epidermal) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.04"/>
                    <measurement group_id="O2" value="0.02" spread="0.01"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.04" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Epidermal) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.04"/>
                    <measurement group_id="O2" value="0.02" spread="0.01"/>
                    <measurement group_id="O3" value="0.02" spread="0.02"/>
                    <measurement group_id="O4" value="0.02" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Epidermal) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.04"/>
                    <measurement group_id="O2" value="0.02" spread="0.02"/>
                    <measurement group_id="O3" value="0.01" spread="0.01"/>
                    <measurement group_id="O4" value="0.02" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Ear, Nose, and Throat (ENT)</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Ear, Nose, and Throat (ENT)</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (ENT) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.4"/>
                    <measurement group_id="O3" value="0.1" spread="0.04"/>
                    <measurement group_id="O4" value="0.1" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (ENT) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.2"/>
                    <measurement group_id="O2" value="0.4" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.03"/>
                    <measurement group_id="O4" value="0.1" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (ENT) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (ENT) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.2"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (ENT) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (ENT) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Behavioral</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Behavioral</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Behavioral) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.5" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Behavioral) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.6" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Behavioral) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.2"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.5" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Behavioral) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.2"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.2" spread="0.01"/>
                    <measurement group_id="O4" value="0.5" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Behavioral) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.2"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.5" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Behavioral) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.1"/>
                    <measurement group_id="O2" value="0.3" spread="0.2"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.5" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Emetic</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Emetic</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Emetic) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" spread="0.04"/>
                    <measurement group_id="O2" value="0.003" spread="0.003"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.1" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Emetic) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.04"/>
                    <measurement group_id="O3" value="0.1" spread="0.04"/>
                    <measurement group_id="O4" value="0.03" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Emetic) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.04"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Emetic) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.1"/>
                    <measurement group_id="O2" value="0.02" spread="0.02"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.1" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Emetic) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.03"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.03" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Emetic) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.1" spread="0.1"/>
                    <measurement group_id="O4" value="0.08" spread="0.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Constipation</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Constipation</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Constipation) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.4" spread="0.2"/>
                    <measurement group_id="O4" value="0.4" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Constipation) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.04"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.3" spread="0.1"/>
                    <measurement group_id="O4" value="0.7" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Constipation) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.01"/>
                    <measurement group_id="O3" value="0.3" spread="0.1"/>
                    <measurement group_id="O4" value="0.6" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Constipation) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.6" spread="0.2"/>
                    <measurement group_id="O4" value="0.7" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Constipation) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.5" spread="0.1"/>
                    <measurement group_id="O4" value="0.7" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Constipation) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.03"/>
                    <measurement group_id="O3" value="0.5" spread="0.2"/>
                    <measurement group_id="O4" value="0.5" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Diarrhea</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Diarrhea</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Diarrhea) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.04"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Diarrhea) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.03"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.1" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Diarrhea) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.3" spread="0.1"/>
                    <measurement group_id="O4" value="0.3" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Diarrhea) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.1"/>
                    <measurement group_id="O3" value="0.4" spread="0.1"/>
                    <measurement group_id="O4" value="0.3" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Diarrhea) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="0.1"/>
                    <measurement group_id="O2" value="0.2" spread="0.1"/>
                    <measurement group_id="O3" value="0.3" spread="0.1"/>
                    <measurement group_id="O4" value="0.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Diarrhea) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="0.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.04"/>
                    <measurement group_id="O3" value="0.2" spread="0.1"/>
                    <measurement group_id="O4" value="0.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Fatigue</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Fatigue</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Fatigue) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="0.3"/>
                    <measurement group_id="O2" value="0.7" spread="0.2"/>
                    <measurement group_id="O3" value="0.7" spread="0.2"/>
                    <measurement group_id="O4" value="0.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Fatigue) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.3"/>
                    <measurement group_id="O2" value="0.6" spread="0.2"/>
                    <measurement group_id="O3" value="0.7" spread="0.2"/>
                    <measurement group_id="O4" value="0.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Fatigue) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.3"/>
                    <measurement group_id="O2" value="0.6" spread="0.2"/>
                    <measurement group_id="O3" value="0.7" spread="0.2"/>
                    <measurement group_id="O4" value="0.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Fatigue) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="0.3"/>
                    <measurement group_id="O2" value="0.4" spread="0.1"/>
                    <measurement group_id="O3" value="0.6" spread="0.2"/>
                    <measurement group_id="O4" value="0.9" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Fatigue) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.3"/>
                    <measurement group_id="O2" value="0.5" spread="0.1"/>
                    <measurement group_id="O3" value="0.6" spread="0.2"/>
                    <measurement group_id="O4" value="0.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Fatigue) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.3"/>
                    <measurement group_id="O2" value="0.5" spread="0.2"/>
                    <measurement group_id="O3" value="0.5" spread="0.2"/>
                    <measurement group_id="O4" value="0.7" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Satiety</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Satiety</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Satiety) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.2"/>
                    <measurement group_id="O2" value="0.7" spread="0.2"/>
                    <measurement group_id="O3" value="0.9" spread="0.2"/>
                    <measurement group_id="O4" value="0.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Satiety) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.2"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.8" spread="0.2"/>
                    <measurement group_id="O4" value="1.1" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Satiety) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.3"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.8" spread="0.2"/>
                    <measurement group_id="O4" value="0.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Satiety) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.3"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.8" spread="0.2"/>
                    <measurement group_id="O4" value="1.0" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Satiety) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" spread="0.3"/>
                    <measurement group_id="O2" value="0.4" spread="0.1"/>
                    <measurement group_id="O3" value="0.9" spread="0.3"/>
                    <measurement group_id="O4" value="0.9" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Satiety) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.3"/>
                    <measurement group_id="O2" value="0.3" spread="0.1"/>
                    <measurement group_id="O3" value="0.9" spread="0.3"/>
                    <measurement group_id="O4" value="0.8" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Bowel Movement</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Daily scores from weeks 2 - 5 were then averaged to arrive at a single value. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Bowel Movement</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Daily scores from weeks 2 - 5 were then averaged to arrive at a single value. Rating is scored from 0 (no symptoms) to 6 (very severe symptoms).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Bowel Mov.) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.55" spread="0.2"/>
                    <measurement group_id="O2" value="1.5" spread="0.2"/>
                    <measurement group_id="O3" value="1.3" spread="0.1"/>
                    <measurement group_id="O4" value="1.5" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Bowel Mov.) Weeks 2-5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="0.1"/>
                    <measurement group_id="O2" value="1.5" spread="0.1"/>
                    <measurement group_id="O3" value="1.5" spread="0.1"/>
                    <measurement group_id="O4" value="1.5" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Bowel Mov.) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.2"/>
                    <measurement group_id="O2" value="1.4" spread="0.1"/>
                    <measurement group_id="O3" value="1.4" spread="0.1"/>
                    <measurement group_id="O4" value="1.6" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Hours of Sleep</title>
        <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Participants recorded the number of hours they slept on the daily questionnaire.</description>
        <time_frame>Weekly for 6 weeks</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Wellness Questionnaires for Hours of Sleep</title>
          <description>Daily Questionnaires consists of 24 symptom items evaluating general wellness. Participants filled out questionnaires nightly for the entire duration of the study (6 weeks). Daily scores were then averaged into weekly scores for each participant. Participants recorded the number of hours they slept on the daily questionnaire.</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>Hours</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Daily Questionnaire (Hours of Sleep) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="0.2"/>
                    <measurement group_id="O2" value="6.6" spread="0.2"/>
                    <measurement group_id="O3" value="7.1" spread="0.1"/>
                    <measurement group_id="O4" value="6.6" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Hours of Sleep) Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" spread="0.1"/>
                    <measurement group_id="O2" value="6.8" spread="0.2"/>
                    <measurement group_id="O3" value="7.1" spread="0.2"/>
                    <measurement group_id="O4" value="6.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Hours of Sleep) Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" spread="0.2"/>
                    <measurement group_id="O2" value="6.8" spread="0.2"/>
                    <measurement group_id="O3" value="7.1" spread="0.2"/>
                    <measurement group_id="O4" value="6.7" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Hours of Sleep) Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="0.2"/>
                    <measurement group_id="O2" value="7.0" spread="0.2"/>
                    <measurement group_id="O3" value="7.3" spread="0.2"/>
                    <measurement group_id="O4" value="6.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Hours of Sleep) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="0.2"/>
                    <measurement group_id="O2" value="7.0" spread="0.2"/>
                    <measurement group_id="O3" value="6.9" spread="0.2"/>
                    <measurement group_id="O4" value="6.9" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Daily Questionnaire (Hours of Sleep) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8" spread="0.2"/>
                    <measurement group_id="O2" value="7.0" spread="0.2"/>
                    <measurement group_id="O3" value="7.1" spread="0.1"/>
                    <measurement group_id="O4" value="6.7" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of the Effect of B. Subtilis R0179 on Gastrointestinal Symptoms Using Questionnaires</title>
        <description>Gastrointestinal Symptom Questionaires (GSRS) was administered during weeks 1, 5, and 6 of the study to evaluate gastrointestinal symptoms. The scale ranges from 1 (no discomfort at all) to 7 (very severe discomfort).</description>
        <time_frame>Weeks 1, 5, and 6</time_frame>
        <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O2">
            <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O3">
            <title>B. Subtilis R0179 (1 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
          <group group_id="O4">
            <title>B. Subtilis R0179 (10 Billion CFU)</title>
            <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of the Effect of B. Subtilis R0179 on Gastrointestinal Symptoms Using Questionnaires</title>
          <description>Gastrointestinal Symptom Questionaires (GSRS) was administered during weeks 1, 5, and 6 of the study to evaluate gastrointestinal symptoms. The scale ranges from 1 (no discomfort at all) to 7 (very severe discomfort).</description>
          <population>Participants who completed all study requirements were included in the baseline analysis population.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="21"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>GSRS (Abdominal Pain) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.1"/>
                    <measurement group_id="O2" value="1.3" spread="0.1"/>
                    <measurement group_id="O3" value="1.4" spread="0.1"/>
                    <measurement group_id="O4" value="1.5" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Abdominal Pain) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.1"/>
                    <measurement group_id="O2" value="1.5" spread="0.1"/>
                    <measurement group_id="O3" value="1.6" spread="0.1"/>
                    <measurement group_id="O4" value="1.6" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Abdominal Pain) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="0.1"/>
                    <measurement group_id="O2" value="1.6" spread="0.2"/>
                    <measurement group_id="O3" value="1.6" spread="0.1"/>
                    <measurement group_id="O4" value="1.3" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Reflux) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.1"/>
                    <measurement group_id="O2" value="1.3" spread="0.2"/>
                    <measurement group_id="O3" value="1.1" spread="0.1"/>
                    <measurement group_id="O4" value="1.1" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Reflux) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.1"/>
                    <measurement group_id="O2" value="1.3" spread="0.2"/>
                    <measurement group_id="O3" value="1.1" spread="0.1"/>
                    <measurement group_id="O4" value="1.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Reflux) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.1"/>
                    <measurement group_id="O2" value="1.3" spread="0.2"/>
                    <measurement group_id="O3" value="1.1" spread="0.1"/>
                    <measurement group_id="O4" value="1.2" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Indigestion) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.1"/>
                    <measurement group_id="O2" value="1.4" spread="0.1"/>
                    <measurement group_id="O3" value="1.5" spread="0.01"/>
                    <measurement group_id="O4" value="1.7" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Indigestion) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="0.2"/>
                    <measurement group_id="O2" value="1.6" spread="0.1"/>
                    <measurement group_id="O3" value="1.9" spread="0.1"/>
                    <measurement group_id="O4" value="1.6" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Indigestion) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="0.1"/>
                    <measurement group_id="O2" value="1.3" spread="0.1"/>
                    <measurement group_id="O3" value="1.6" spread="0.1"/>
                    <measurement group_id="O4" value="1.7" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Constipation) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.1"/>
                    <measurement group_id="O2" value="1.1" spread="0.1"/>
                    <measurement group_id="O3" value="1.4" spread="0.1"/>
                    <measurement group_id="O4" value="1.4" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Constipation) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.1"/>
                    <measurement group_id="O2" value="1.2" spread="0.1"/>
                    <measurement group_id="O3" value="1.6" spread="0.2"/>
                    <measurement group_id="O4" value="1.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Constipation) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.1"/>
                    <measurement group_id="O2" value="1.2" spread="0.1"/>
                    <measurement group_id="O3" value="1.6" spread="0.2"/>
                    <measurement group_id="O4" value="1.7" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Diarrhea) Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.1"/>
                    <measurement group_id="O2" value="1.2" spread="0.1"/>
                    <measurement group_id="O3" value="1.3" spread="0.2"/>
                    <measurement group_id="O4" value="1.4" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Diarrhea) Week 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="0.2"/>
                    <measurement group_id="O2" value="1.2" spread="0.1"/>
                    <measurement group_id="O3" value="1.6" spread="0.2"/>
                    <measurement group_id="O4" value="1.5" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GSRS (Diarrhea) Week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="0.2"/>
                    <measurement group_id="O2" value="1.3" spread="0.1"/>
                    <measurement group_id="O3" value="1.4" spread="0.2"/>
                    <measurement group_id="O4" value="1.3" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data monitoring adverse events was collected over the study period.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Placebo (starch, magnesium stearate, citric acid) capsules once daily for 4 weeks.
Placebo: Placebo (starch, magnesium stearate, citric acid) capsules for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="E2">
          <title>B. Subtilis R0179 (0.1 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 0.1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="E3">
          <title>B. Subtilis R0179 (1 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 1 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
        <group group_id="E4">
          <title>B. Subtilis R0179 (10 Billion CFU)</title>
          <description>B. subtilis R0179 (approximately 10 billion CFU/capsule) once daily for 4 weeks.
B. subtilis R0179: B. subtilis R0179 for a period of 4 weeks. One capsule per day.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <description>One participant reported a serious adverse event of hospitalization with an admitting diagnosis of hypotension, but did not discontinue probiotic consumption and completed the study.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrheal Symptoms</sub_title>
                <description>One participant in the 0.1 billion CFU treatment group experienced diarrheal symptoms and completed the study, this event did not occur in any other participants and did not persist.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Itchiness and Redness Symptoms</sub_title>
                <description>A participant in the 10 billion CFU treatment group experienced itchiness/redness symptoms that were sporadic and persisted for several days. The participant voluntarily withdrew from the study, these symptoms did not occur in any other participants.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Wendy Dahl</name_or_title>
      <organization>Department of Food Science and Human Nutrition, University of Florida</organization>
      <phone>352-392-1991 ext 224</phone>
      <email>wdahl@ufl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

